IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN
XXV
XXV was delisted on the 12th of April, 2018.
3 hedge funds and large institutions have $3.15M invested in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN in 2014 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
148% more call options, than puts
Call options by funds: $67.3M | Put options by funds: $27.2M
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 3 → 3 (0)
18% less capital invested
Capital invested by funds: $3.83M → $3.15M (-$683K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$168K |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
+$38 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$844K |
XXV Hedge Fund Activity: Q4 2014 in Review
3 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) for Q4 2014, worth a combined $3.15M — down 18% from $3.83M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new XXV positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, adding an estimated $168K. The largest seller was Barclays, exiting entirely with an estimated $844K sold.
- 3 institutional investors held IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $3.15M of IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN stock for Q4 2014, down 18% quarter-over-quarter.
- 2 funds opened new IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN positions in Q4 2014 and 1 closed out, a net change of +1 holder.
- The largest IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN buyer in Q4 2014 was Virtu Financial, an estimated $168K added.
- The largest IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN seller in Q4 2014 was Barclays, an estimated $844K sold.
Based on aggregated 13F filings for Q4 2014.